Omni Crest – High Alpha Built on High Safety
A disciplined Flexi-cap PMS built to Hunt for Alpha across market capitalizations targeting long-term compounding through various market cycles.
What is Omni Crest ?
Omni Crest is designed for accomplished investors at the peak of their careers, who value stability, discipline, and long-term wealth creation. It acts as a core compounding engine built to grow steadily across market cycles.
For investors who want:
A low churn portfolio built for multi-decade compounding
Exposure to a portfolio designed to Hunt for Alpha across market caps
A risk-managed PMS with a scientific safety-first framework
A reliable core portfolio to anchor long-term wealth plans
How Omni Crest Generates Alpha
The Safety and Alpha Engine
Omni Crest builds high alpha on high safety. By removing fragile companies early, strong businesses compound uninterrupted—just as aircraft achieve speed through uncompromising safety, we drive performance through a solid safety foundation.
Safety Foundation
A scientific framework that filters out capital destroyers by enforcing governance checks, balance sheet strength, and business durability.
Yield
Steady returns from businesses with strong free cash flows and consistent dividends.
Growth
Exposure to companies aligned with India’s long-term structural growth vectors.
Re-rating
Owning undervalued but high quality businesses positioned for valuation expansion as fundamentals get recognized.
Omni Crest Strategies
Omni SuperNormal India
The flagship multi-cap PMS focused on durable, high quality Indian companies selected for sustainable growth and re-rating potential.
Omni SuperPay
A differentiated PMS offering long-term compounding along with monthly cash flows through NAV-linked payouts.
Omni Centurion
A focused mid and small-cap PMS investing in emerging growth champions that meet strict safety and quality criteria.
A Proven Research Process That Protects and Compounds
Omni Crest is powered by Omniscience’s proven research process, refined over 8 to 10 years to deliver consistent, durable, and risk-managed long-term outcomes.
Why investors trust Omni Crest:
Research process tested across multiple market cycle
Deep business-first analysis and strong risk controls
Low churn, high conviction portfolio construction
Consistent and disciplined approach in all market conditions
Transparent scientific framework focused on long-term wealth creation
FAQS
What type of investor is Omni Crest ideal for?
Investors at the peak of their careers who seek a stable, long-term, quality-driven compounding portfolio.
How long should I stay invested in Omni Crest?
Five years and above for meaningful compounding.
Is Omni Crest suitable as a core portfolio holding?
Yes. It is designed to function as a core PMS allocation for long-term wealth creation.
Does Omni Crest take aggressive short-term calls?
No. The approach is stable, research-driven, and long-term.
How does Omni Crest handle market volatility?
By owning strong balance sheet companies that can navigate different market environments.
Is Omni Crest a high churn PMS?
No. The philosophy is low churn and high conviction.
Omniscience Asset Management, asset management division of Omniscience Capital Advisors Pvt. Ltd. which is registered as a Portfolio Manager with SEBI with a valid registration No. INP000009597 and CIN U93000MH2017PTC290053. Principal Officer is Ashwini Shami (Contact No. 9892140540, Email: ashwini.shami@omnisciencecapital.com) and Compliance Officer is Chanchal Manglunia (Contact No. 9320816319, Email: chanchal.manglunia@omnisciencecapital.com). Local office address of Securities and Exchange Board of India is SEBI Bhavan, C4-A, G Block, BKC, Mumbai – 400 051.
Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Any securities quoted above are for illustration purposes only and are not recommendations unless explicitly stated as investment advice. Nothing in this communication should be construed as implying assured returns, minimum returns, target returns, percentage accuracy, or service provision until a target return is achieved. Furthermore, no content herein should suggest that the investment advice, recommendations, or research reports are risk-free or insulated from market fluctuations, nor that they can generate returns with any level of certainty.
The information contained in this electronic communication is intended solely for the individual(s) or entity to which it is addressed. It may contain proprietary, confidential and/or legally privileged information. Any review, retransmission, dissemination, printing, copying or other use of, or taking any action in reliance on the contents of this information by person(s) or entities other than the intended recipient is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us by responding to this email or telephone and immediately and permanently delete all copies of this message and any attachments from your system(s). The contents of this message do not necessarily represent OmniScience Capital views or policies. Computer viruses can be transmitted via email. OmniScience Capital attempt to sweep e-mails and attachments for viruses, it does not guarantee that either are virus free. The recipient should check this email and any attachments for the presence of viruses. OmniScience Capital do not accept any liability for any damage sustained as a result of viruses. Our company, along with its directors, employees, and associates, may currently hold or may have previously held positions in the securities mentioned. These positions may be reflected in investment recommendations or research reports issued by us. Please note that such holdings are accurate as of the time of this post and may change in the future. For detailed disclosures regarding financial interests and potential conflicts of interest, kindly visit: https://www.omnisciencecapital.com/disclosure/